Related Experiment Video
Updated: Sep 25, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Long non-coding RNA LINC00511 facilitates colon cancer development through regulating microRNA-625-5p to target WEE1
Xiaowu Qian1, Chun Jiang2, Zhengtai Zhu3
1Department of Geriatrics, Taizhou People's Hospital (Taizhou People's Hospital affiliated to Nanjing Medical University), 225300, Taizhou, Jiangsu, China. Qianxiaowu89898@163.com.
Abstract:
The altered part of long non-coding RNA LINC00511 (LINC00511) is extensively discussed in malignancies. Finitely, the mechanism of LINC00511 in colon cancer (CC) development lacks thorough explorations. Hence, this work is started from the LINC00511-mediated microRNA (miR)-625-5p/WEE1 axis in the CC process. LINC00511, miR-625-5p, and WEE1 levels were tested in CC tissues and cells. Subcellular localization of LINC00511 was clarified. CC cells were transfected with oligonucleotides that altered LINC00511, and miR-625-5p expression to define their performance in CC cell progression. The tumorigenic ability of cells was verified in xenografted tumors. CC tissues and cells highly expressed LINC00511 and WEE1 and lowly expressed miR-625-5p. LINC00511 was mainly localized in the cytoplasm. Deleted LINC00511 or restored miR-625-5p delayed cellular growth in CC. LINC00511 sponged miR-625-5p to target WEE1. Silenced miR-625-5p mitigated the role of depleted LINC00511, while inhibited WEE1 rescued the effect of silenced miR-625-5p on the biological functions of CC cells. It is summarized that down-regulated LINC00511 obstructs tumorigenesis of CC through restoring miR-625-5p and silencing WEE1, consolidating a basal reference for CC-oriented therapy.
Insights
Down-regulating long non-coding RNA LINC00511 inhibits colon cancer progression by targeting microRNA miR-625-5p and WEE1. This finding offers a potential therapeutic strategy for colon cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNA LINC00511 is implicated in various cancers.
- The specific role and mechanism of LINC00511 in colon cancer (CC) remain underexplored.
- Understanding novel molecular pathways is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the mechanism of LINC00511 in colon cancer development.
- To elucidate the role of the LINC00511-mediated microRNA (miR)-625-5p/WEE1 axis in colon cancer.
- To provide a basis for colon cancer-oriented therapy.
Main Methods:
- Quantification of LINC00511, miR-625-5p, and WEE1 levels in colon cancer tissues and cells.
- Determination of LINC00511 subcellular localization.
- In vitro transfection experiments to modulate LINC00511 and miR-625-5p expression.
- In vivo tumorigenicity assays using xenografted tumors.
Main Results:
- LINC00511 and WEE1 were upregulated, while miR-625-5p was downregulated in colon cancer tissues and cells.
- LINC00511 was primarily localized in the cytoplasm.
- Reduced LINC00511 or restored miR-625-5p expression inhibited colon cancer cell growth.
- LINC00511 acts as a molecular sponge for miR-625-5p, thereby targeting WEE1.
- Modulation of the LINC00511/miR-625-5p/WEE1 axis significantly affected colon cancer cell biological functions.
Conclusions:
- Downregulation of LINC00511 inhibits colon cancer tumorigenesis.
- The mechanism involves the restoration of miR-625-5p and subsequent silencing of WEE1.
- This pathway presents a potential therapeutic target for colon cancer treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
Non-LTR Retrotransposons
Experimental RNAi
Canonical Wnt Signaling Pathway
Abnormal Proliferation

